OCT Biomarkers of Intermediate Age-Related Macular Degeneration (iAMD) and Their Correlation with Atrophy Development

SPECTRALIS B-scan
SPECTRALIS B-scan illustrating (A) SDD (B) hDC (C) IHRF (D) Thin DLS
Image courtesy:  Yu Wakatsuki & Srinivas R Sadda

This journal article highlights the value of SPECTRALIS OCT volume scans in identifying biomarkers of age-related macular degeneration. The retrospective analysis found several baseline features associated with a significantly greater risk for the development of complete retinal pigment epithelium and outer retinal atrophy at 2 years. The authors conclude that these biomarkers may be useful for prognostication, risk stratification, and selection of patients for future early intervention clinical trials

Learn more here andHere

 

For more valuable information about our products, educational offerings, learning materials and events 
Subscribe to our Newsletter orContact us